CHina Adrenal Venous saMPling InvestigatiON

Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.

NCT Number	NCT07252284
Lead Sponsor	Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions	Hyperaldosteronism, Adrenal Venous Sampling, Adrenalectomy
Enrollment	5,000 participants
Start Date	2025-05-01
Primary Completion	2029-08-31 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-26